AG NPP709 is currently available on the market; even so, no research has investigated the result of AG NPP709 in individuals with COPD. As a result, the aim of this review was to evaluate the efficacy of AG NPP709 in patients with Serious bronchitis form COPD.Berberine suppresses inflammatory brokers-induced interleukin-1beta and tumor necrosis asp